Anti-TNF-alpha antibody treatment for Crohn's disease

Research and Clinical Forums

Volumn 22, Issue 2, 2000, Pages 129-135

  Bell, S ^a   Kamm, M A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; COLLAGEN; CYCLOSPORIN; CYTOKINE; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CLINICAL TRIAL; CONFERENCE PAPER; CROHN DISEASE; DRUG BINDING; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0034045592     PISSN: 01433083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)